Personalised mRNA Cancer Vaccine Cuts Melanoma Recurrence
Moderna and Merck report that their personalised mRNA cancer vaccine combined with Keytruda cuts melanoma recurrence or death risk by 42%.
22 Oct 22:28 · Greek City Times
last updated on 23 Oct 00:34